Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the quick ratio (acid-test) high or low?
The quick ratio (acid-test) of 5.31 is 50% below its 5-year average of 10.58, near the low end of its 5-year range (3.34–22.32).
As of the fiscal period ended Tuesday, June 30, 2026. 18.57% below its 12-month average of 6.52.
Reported quarterly quick ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 5.31.
QUICK RATIO (ACID-TEST)
5.31
QUICK RATIO (ACID-TEST) AVG TTM
6.52
QUICK RATIO (ACID-TEST) AVG 3Y
6.98
QUICK RATIO (ACID-TEST) AVG 5Y
10.58
QUICK RATIO (ACID-TEST) AVG 10Y
8.71
QUICK RATIO (ACID-TEST) AVG 15Y
N/A
QUICK RATIO (ACID-TEST) AVG 20Y
N/A
CURRENT VS TTM AVG
-18.57%
CURRENT VS 3Y AVG
-23.92%
CURRENT VS 5Y AVG
-49.81%
CURRENT VS 10Y AVG
-39.09%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
3.35
median of 849 covered companies
CURRENT VS SECTOR MEDIAN
+58.45%
vs the sector median at left
Profound Medical Corp.
Market Cap
$222.75M
Quick Ratio (Acid-Test)
5.31
TTM Avg
6.52
3Y Avg
6.98
5Y Avg
10.58
Market Cap
$223.48M
Quick Ratio (Acid-Test)
21.96
TTM Avg
18.45
3Y Avg
17.11
5Y Avg
21.15
Market Cap
$216.82M
Quick Ratio (Acid-Test)
344.31
TTM Avg
177.51
3Y Avg
95.13
5Y Avg
76.52
Market Cap
$229.55M
Quick Ratio (Acid-Test)
2.85
TTM Avg
2.31
3Y Avg
2.01
5Y Avg
2.00
Market Cap
$214.64M
Quick Ratio (Acid-Test)
5.13
TTM Avg
3.45
3Y Avg
2.59
5Y Avg
2.27
Market Cap
$214.30M
Quick Ratio (Acid-Test)
5.36
TTM Avg
6.17
3Y Avg
11.50
5Y Avg
11.99
Market Cap
$232.32M
Quick Ratio (Acid-Test)
2.96
TTM Avg
4.42
3Y Avg
4.46
5Y Avg
4.62
Market Cap
$233.51M
Quick Ratio (Acid-Test)
10.14
TTM Avg
15.36
3Y Avg
19.42
5Y Avg
27.25
| NAME | MARKET CAP | QUICK RATIO (ACID-TEST) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Profound Medical Corp. (PROF) | $222.75M | 5.31 | 6.52 | 6.98 | 10.58 |
| Keros Therapeutics, Inc. (KROS)vs › | $223.48M | 21.96 | 18.45 | 17.11 | 21.15 |
| Anbio Biotechnology Class A Ordinary Shares (NNNN)vs › | $216.82M | 344.31 | 177.51 | 95.13 | 76.52 |
| Vogenx Inc. (VOGX)vs › | $229.03M | N/A | N/A | N/A | N/A |
| Biodesix, Inc. (BDSX)vs › | $229.55M | 2.85 | 2.31 | 2.01 | 2.00 |
| Niagen Bioscience Inc (NAGE)vs › | $214.64M | 5.13 | 3.45 | 2.59 | 2.27 |
| Lyell Immunopharma, Inc. (LYEL)vs › | $214.30M | 5.36 | 6.17 | 11.50 | 11.99 |
| MacroGenics, Inc. (MGNX)vs › | $232.32M | 2.96 | 4.42 | 4.46 | 4.62 |
| Nautilus Biotechnolgy, Inc. (NAUT)vs › | $233.51M | 10.14 | 15.36 | 19.42 | 27.25 |
| Prelude Therapeutics Incorporated (PRLD)vs › | $211.79M | 4.07 | 3.65 | 6.88 | 10.38 |
Quick Ratio
5.31
Excludes inventory
Current Ratio
6.45
Includes inventory
Quick Ratio = (Current Assets − Inventory) / Current Liabilities
The quick ratio is a stricter liquidity measure that excludes inventory, showing the ability to meet short-term obligations with the most liquid assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | QUICK RATIO (ACID-TEST) |
|---|---|
| 2026-06-30 | 5.31 |
| 2026-03-31 | 5.71 |
| 2025-12-31 | 11.17 |
| 2025-09-30 | 3.34 |
| 2025-06-30 | 7.07 |
| 2025-03-31 | 10.03 |
| 2024-12-31 | 9.64 |
| 2024-09-30 | 5.16 |
| 2024-06-30 | 7.42 |
| 2024-03-31 | 8.25 |
| 2023-12-31 | 5.48 |
| 2023-09-30 | 7.88 |
| 2023-06-30 | 4.25 |
| 2023-03-31 | 10.65 |
| 2022-12-31 | 12.92 |
| 2022-09-30 | 15.11 |
| 2022-06-30 | 17.23 |
| 2022-03-31 | 16.30 |
| 2021-12-31 | 16.78 |
| 2021-09-30 | 22.32 |
| 2021-06-30 | 20.09 |
| 2021-03-31 | 21.53 |
| 2020-12-31 | 19.22 |
| 2020-09-30 | 26.53 |
| 2020-06-30 | 12.66 |
| 2020-03-31 | 15.11 |
| 2019-12-31 | 2.33 |
| 2019-09-30 | 3.20 |
| 2019-06-30 | 3.22 |
| 2019-03-31 | 4.19 |
| 2018-12-31 | 5.93 |
| 2018-09-30 | 8.65 |
| 2018-06-30 | 3.93 |
| 2018-03-31 | 7.13 |
| 2017-12-31 | 1.51 |
| 2017-09-30 | 1.91 |
| 2017-06-30 | 2.22 |
| 2017-03-31 | 2.78 |
| 2016-12-31 | 4.46 |
| 2016-09-30 | 2.31 |
| 2016-06-30 | 4.17 |
| 2016-03-31 | 8.85 |
| 2015-12-31 | 16.52 |
| 2015-09-30 | 12.77 |
| 2015-06-30 | 13.29 |
| 2015-03-31 | 0.03 |
| 2014-12-31 | 14.32 |
| 2014-09-30 | 46.31 |
| 2014-06-30 | 0.00 |
| 2014-03-31 | 0.00 |
